Department of Orthopaedic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Department of Pulmonary, Critical Care, and Sleep Medicine, Mount Sinai School of Medicine, New York, NY.
J Bone Joint Surg Am. 2020 Jul 1;102(13):1109-1115. doi: 10.2106/JBJS.20.00452.
Improvements in technology and a push toward value-based health care have poised the telemedicine industry for growth; however, despite the benefits of virtual care, widespread implementation had not occurred until the coronavirus 2019 (COVID-19) pandemic. Powerful barriers have hindered the widespread adoption of telemedicine, including lack of awareness, implementation costs, inefficiencies introduced, difficulty performing physical examinations, overall lack of perceived benefit of virtual care, negative financial implications, concern for medicolegal liability, and regulatory restrictions. Some of these challenges have been addressed with temporary state and federal mandates in response to the COVID-19 pandemic; however, continued investment in systems and technology as well as refinement of regulations around telemedicine are needed to sustain widespread adoption by patients and providers.
技术的进步和向基于价值的医疗保健的推动使远程医疗行业得以发展;然而,尽管虚拟护理有诸多好处,但直到 2019 年冠状病毒病(COVID-19)大流行,虚拟护理才得到广泛应用。阻碍远程医疗广泛应用的因素有很多,包括缺乏认识、实施成本、引入的效率低下、难以进行体格检查、对虚拟护理整体益处的认知不足、负面的财务影响、对医疗法律责任的担忧以及监管限制。其中一些挑战已经通过应对 COVID-19 大流行的临时州和联邦命令得到解决;然而,需要继续投资于系统和技术,并完善远程医疗监管,以维持患者和提供者的广泛采用。